FORESIGHT AUTONOMOUS-SP ADR (FRSX) Fundamental Analysis & Valuation
NASDAQ:FRSX • US3455232039
Current stock price
2.02 USD
+0.01 (+0.5%)
At close:
2.02 USD
0 (0%)
After Hours:
This FRSX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. FRSX Profitability Analysis
1.1 Basic Checks
- In the past year FRSX has reported negative net income.
- In the past year FRSX has reported a negative cash flow from operations.
- In the past 5 years FRSX always reported negative net income.
- FRSX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- FRSX has a Return On Assets of -144.89%. This is amonst the worse of the industry: FRSX underperforms 95.24% of its industry peers.
- FRSX has a worse Return On Equity (-194.18%) than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -144.89% | ||
| ROE | -194.18% | ||
| ROIC | N/A |
ROA(3y)-118.18%
ROA(5y)-89.71%
ROE(3y)-165.8%
ROE(5y)-120.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 64.82%, FRSX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- In the last couple of years the Gross Margin of FRSX has grown nicely.
- The Profit Margin and Operating Margin are not available for FRSX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 64.82% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.16%
GM growth 5YN/A
2. FRSX Health Analysis
2.1 Basic Checks
- FRSX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for FRSX has been increased compared to 1 year ago.
- FRSX has more shares outstanding than it did 5 years ago.
- FRSX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -26.67, we must say that FRSX is in the distress zone and has some risk of bankruptcy.
- FRSX's Altman-Z score of -26.67 is on the low side compared to the rest of the industry. FRSX is outperformed by 88.10% of its industry peers.
- FRSX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -26.67 |
ROIC/WACCN/A
WACC8.53%
2.3 Liquidity
- A Current Ratio of 3.30 indicates that FRSX has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 3.30, FRSX belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
- A Quick Ratio of 3.30 indicates that FRSX has no problem at all paying its short term obligations.
- FRSX has a better Quick ratio (3.30) than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.3 | ||
| Quick Ratio | 3.3 |
3. FRSX Growth Analysis
3.1 Past
- FRSX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.13%, which is quite impressive.
- Looking at the last year, FRSX shows a decrease in Revenue. The Revenue has decreased by -8.72% in the last year.
- The Revenue for FRSX have been decreasing by -10.22% on average. This is quite bad
EPS 1Y (TTM)28.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-161.66%
Revenue 1Y (TTM)-8.72%
Revenue growth 3Y-10.22%
Revenue growth 5YN/A
Sales Q2Q%294.06%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. FRSX Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for FRSX. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. FRSX Dividend Analysis
5.1 Amount
- FRSX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRSX Fundamentals: All Metrics, Ratios and Statistics
2.02
+0.01 (+0.5%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)11-25 2022-11-25/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change-99.99%
Ins Owners0.05%
Ins Owner Change0%
Market Cap4.84M
Revenue(TTM)398.00K
Net Income(TTM)-12.10M
Analysts82.86
Price TargetN/A
Short Float %2.3%
Short Ratio0.41
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 12.16 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.78 | ||
| P/tB | 0.78 | ||
| EV/EBITDA | N/A |
EPS(TTM)-5.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.37
FCFYN/A
OCF(TTM)-4.36
OCFYN/A
SpS0.17
BVpS2.6
TBVpS2.6
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -144.89% | ||
| ROE | -194.18% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 64.82% | ||
| FCFM | N/A |
ROA(3y)-118.18%
ROA(5y)-89.71%
ROE(3y)-165.8%
ROE(5y)-120.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.16%
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 6.28% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.3 | ||
| Quick Ratio | 3.3 | ||
| Altman-Z | -26.67 |
F-Score4
WACC8.53%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)15.15%
Cap/Sales(5y)59.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-161.66%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.72%
Revenue growth 3Y-10.22%
Revenue growth 5YN/A
Sales Q2Q%294.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.45%
OCF growth 3YN/A
OCF growth 5YN/A
FORESIGHT AUTONOMOUS-SP ADR / FRSX Fundamental Analysis FAQ
What is the fundamental rating for FRSX stock?
ChartMill assigns a fundamental rating of 2 / 10 to FRSX.
What is the valuation status for FRSX stock?
ChartMill assigns a valuation rating of 0 / 10 to FORESIGHT AUTONOMOUS-SP ADR (FRSX). This can be considered as Overvalued.
How profitable is FORESIGHT AUTONOMOUS-SP ADR (FRSX) stock?
FORESIGHT AUTONOMOUS-SP ADR (FRSX) has a profitability rating of 1 / 10.